Published in Cesk Gynekol on June 01, 1987
Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet (1999) 0.88
[Lysophosphatidic acid in ovarian cancer patients]. Ceska Gynekol (2006) 0.87
Lysophosphatidic acid: an ovarian cancer marker. Eur J Gynaecol Oncol (2008) 0.85
The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries. Onkologie (2001) 0.79
[Pregnancy after uterine artery embolization in uterine myoma]. Ceska Gynekol (2004) 0.77
Non-specific leucocyte migration inhibition of gynaecological carcinoma patients. Clin Exp Immunol (1979) 0.75
[Circulating immunocomplexes in women with gynecologic tumors]. Cesk Gynekol (1983) 0.75
[Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test]. Cas Lek Cesk (1987) 0.75
[The husband's share in a sterile marriage]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1973) 0.75
[Dependence of leukocyte migration inhibition on the progress and activity of gynecological tumours (author's transl)]. Cesk Gynekol (1979) 0.75
[Immunodiagnosis in women with ovarian carcinoma]. Cesk Gynekol (1987) 0.75
Steroids pretreatment in assisted reproduction cycles. J Steroid Biochem Mol Biol (2013) 0.75
[Use of orosomucoid and prealbumin in the differential diagnosis of ovarian diseases]. Cesk Gynekol (1988) 0.75
Leucocyte migration inhibition test in patients with gynaecologic malignancy. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1981) 0.75
Hemangiopericytoma of the uterus: an unusual cause of the postmenopausal metrorrhagia. Acta Obstet Gynecol Scand (1995) 0.75
[Gynecological-surgical cooperation in abdominal emergencies (author's transl)]. Cesk Gynekol (1974) 0.75
[Proteomics and biomarkers for detection of cervical cancer]. Ceska Gynekol (2009) 0.75
[Diurnal profile of foetal motility during normal and risk pregnancy (author's transl)]. Cesk Gynekol (1981) 0.75
[The value of estimation of ABH isoantigens in gynecological tumors (author's transl)]. Cesk Gynekol (1981) 0.75
[Proteomics and biomarkers for detection of ovarian cancer]. Ceska Gynekol (2009) 0.75
[Incidence of CA 125 antigen in the blood of women with ovarian carcinoma]. Cesk Gynekol (1987) 0.75
[Methods of selection of cutoff points in the development and interpretation of diagnostic tests]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1991) 0.75
[Long GnRH agonist vs. GnRH antagonist protocol in randomized controlled trial in unselected patients--hormonal and cycle characteristics--pilot study]. Ceska Gynekol (2009) 0.75
[Nonspecific immunoreactivity in women with dysplasia and cancer of the uterine cervix]. Cesk Gynekol (1984) 0.75
Effects of levamisole on immunity in patients with gynecological carcinoma. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1982) 0.75
[Side-effects of levamisol in women suffering with malignant tumours (author's transl)]. Cesk Gynekol (1981) 0.75
[Cooperation between the surgeon and gynecologist in the operating room]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1974) 0.75
[Use of the gravidogram in the prenatal care and diagnosis of pathological states in pregnancy]. Cesk Gynekol (1981) 0.75
[Relation of serum immunoglobulins and the activity, progress and treatment of gynecologic tumors]. Cesk Gynekol (1983) 0.75
[Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor]. Cas Lek Cesk (1984) 0.75
[Chemoresistance/Chemosensitivity of ovarian cancer--a case report]. Ceska Gynekol (2008) 0.75
[Proteomics and biomarkers for detection of preterm labor: a systematic review]. Ceska Gynekol (2011) 0.75
[Complications of surgical treatment of malignant ovarian tumors]. Cesk Gynekol (1983) 0.75
Possibilities and problems of immunodiagnosis in patients with gynaecological carcinomas. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove (1984) 0.75
[Use of the mixed agglutination test for the demonstration of tissue antigens in the uterine cervix and oviduct]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1977) 0.75
[Multiple tumours found in women with ovary cancer (author's transl)]. Cesk Gynekol (1979) 0.75
Subcapsular hepatic hematoma. Int J Gynaecol Obstet (2003) 0.75
[Foetal motility and newborn's condition after delivery (author's transl)]. Cesk Gynekol (1981) 0.75
[Nonspecific humoral immunity in women with the climacteric syndrome]. Cesk Gynekol (1987) 0.75
[Changes in the endometrium in treatment of breast carcinoma with tamoxifen]. Ceska Gynekol (1997) 0.75
[The influence of irradiation and chemotherapy on immunity of female patients with malignant tumour (author's transl)]. Cesk Gynekol (1979) 0.75
[Mono-follicular development--the objective of ovulation induction with follitropin beta combined with intrauterine insemination]. Ceska Gynekol (2008) 0.75
[The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1980) 0.75
[Proteomics and biomarkers for detection of endometrial carcinoma]. Ceska Gynekol (2009) 0.75
[Amniotic fluid interleukin 6 levels in preterm premature rupture of membranes]. Ceska Gynekol (2009) 0.75
[Fertility of men living in sterile matrimony (author's transl)]. Cesk Gynekol (1977) 0.75
[Resistance/sensitivity in vitro in ovarian cancer patients]. Ceska Gynekol (2010) 0.75
[Para-aortic lymphadenectomy in gynecology. Theoretical principles, basic approach and practical suggestions]. Ceska Gynekol (2003) 0.75
[Inhibition of leucocyte migration in women with ovarian carcinoma, and its dependence on the quantity of lymphocytes forming E-rosettes (author's transl)]. Cas Lek Cesk (1981) 0.75
The influence of latent hyperprolactinaemia on the levels of LH, FSH, E2 and T in the midfollicular phase of the cycle. Arch Gynecol Obstet (1997) 0.75
[Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients]. Ceska Gynekol (2011) 0.75
[Amniotic fluid heat shock protein 70 concentration in preterm premature rupture of membranes]. Ceska Gynekol (2009) 0.75
[Principles of integrated medical education]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl (1973) 0.75
[ABH antigens evidenced in the cervix-tissue (author's transl)]. Cesk Gynekol (1977) 0.75